Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hodgkin Disease (HD) Banking Study

NCT00900250 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00900250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00900250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hodgkin Disease (HD) Banking Study
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Completed
Start date
October 23, 2006
Completion date
March 31, 2019
Enrollment
1,271 (actual)
Sites
183

Conditions

As the registry lists them; a condition with its own page is linked.

ann arbor stage i childhood hodgkin lymphoma, ann arbor stage ii childhood hodgkin lymphoma, ann arbor stage iii childhood hodgkin lymphoma, ann arbor stage iv childhood hodgkin lymphoma, refractory childhood hodgkin lymphoma